MUC1 and colonic neoplasm: The results of the present study show that by the combination of MUC1 DNA and BMDCs, an immune response could be elicited to eliminate MUC1-expressing tumor cells at an early stage of carcinogenesis, providing evidence that MUC1 tolerance can be overcome in this clinically relevant colon cancer model.